Adam Dicker

Citata da

	Tutte	Dal 2020
Citazioni	30204	12651
Indice H	90	56
i10-index	337	190

2800

1400

700

2100

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202576 101 141 121 182 235 301 364 396 429 456 476 512 609 831 1009 1210 1455 1863 1948 1972 2007 2359 2741 2463 2292 2378 379

Accesso pubblico

Visualizza tutto

171 articoli

18 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Leonard GomellaProfessor of Urology, Thomas Jefferson UniversityEmail verificata su jefferson.edu
Elai DavicioniVeracyteEmail verificata su veracyte.com
Edouard J TrabulsiProfessor of Urology, Thomas Jefferson UniversityEmail verificata su jefferson.edu
Yaacov Richard LawrenceChair, The Benjamin Davidai Dep. Radiation Oncology, Sheba Medical CenterEmail verificata su sheba.health.gov.il
Ulrich RodeckThomas Jefferson UniversityEmail verificata su jefferson.edu
Edward M Schaeffer, MD PhDNorthwestern UniversityEmail verificata su northwestern.edu
Walter CurranChief of Piedmont Oncology InstituteEmail verificata su piedmont.org
Tarun K. Podder, PhDProfessor, Case Western Reserve UniversityEmail verificata su case.edu
Eric A. KleinChairman Emeritus, Glickman Urological and Kidney Institute, Cleveland ClinicEmail verificata su ccf.org
Nicholas G Zaorsky, MD MSUniversity Hospitals Seidman Cancer Center, Case Western Reserve UniversityEmail verificata su uhhospitals.org
Nitin OhriAlbert Einstein College of Medicine, Montefiore Medical CenterEmail verificata su montefiore.org
Stephen J FreedlandCedars-Sinai Medical CenterEmail verificata su cshs.org
Randy BurdArizona State UniversityEmail verificata su asu.edu
Matthew SchiewerKimmel Cancer Center at Thomas Jefferson UniversityEmail verificata su jefferson.edu
Peter McCueDirector of Pathology, Jefferson UniversityEmail verificata su jefferson.edu
Terry HyslopProfessor, Division of Biostatistics, Thomas Jefferson UniversityEmail verificata su jefferson.edu
Firas AbdollahVattikuti Urology Institute & VUI Center for Outcomes Research Analytics and Evaluation (VCOREEmail verificata su hfhs.org
Colin ChampAssociate Professor of Radiation Oncology, Duke University Medical CenterEmail verificata su duke.edu
Paul L NguyenProfessor of Radiation Oncology, Dana-Farber/Brigham and Women's, Harvard Medical SchoolEmail verificata su LROC.harvard.edu
Parsaoran HutapeaProfessor, Temple University; ASME FellowEmail verificata su temple.edu

Segui

Adam Dicker

Thomas Jefferson University

Email verificata su jefferson.edu


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options LE Schnipper, NE Davidson, DS Wollins, C Tyne, DW Blayney, D Blum, ... Journal of Clinical Oncology 33 (23), 2563-2577, 2015	1036	2015
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020	997	2020
Radiation dose–volume effects in the brain YR Lawrence, XA Li, I El Naqa, CA Hahn, LB Marks, TE Merchant, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S20-S27, 2010	909	2010
Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received LE Schnipper, NE Davidson, DS Wollins, DW Blayney, AP Dicker, ... Journal of Clinical Oncology 34 (24), 2925-2934, 2016	694	2016
Microsurgical inguinal varicocelectomy with delivery of the testis: an artery and lymphatic sparing technique M Goldstein, BR Gilbert, AP Dicker, J Dwosh, C Gnecco The Journal of urology 148 (6), 1808-1811, 1992	678	1992
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results … P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ... BJU international 109, 22-29, 2012	601	2012
Zebrafish: an emerging model system for human disease and drug discovery G Kari, U Rodeck, AP Dicker Clinical Pharmacology & Therapeutics 82 (1), 70-80, 2007	596	2007
Dihydrofolate reductase as a therapeutic target BI Schweitzer, AP Dicker, JR Bertino The FASEB journal 4 (8), 2441-2452, 1990	529	1990
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer JJ Farrell, H Elsaleh, M Garcia, R Lai, A Ammar, WF Regine, R Abrams, ... Gastroenterology 136 (1), 187-195, 2009	517	2009
Dual roles of PARP-1 promote cancer growth and progression MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ... Cancer discovery 2 (12), 1134-1149, 2012	484	2012
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction P Wachsberger, R Burd, AP Dicker Clinical cancer research 9 (6), 1957-1971, 2003	477	2003
A hormone–DNA repair circuit governs the response to genotoxic insult JF Goodwin, MJ Schiewer, JL Dean, RS Schrecengost, R de Leeuw, ... Cancer discovery 3 (11), 1254-1271, 2013	406	2013
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas SE Fogh, DW Andrews, J Glass, W Curran, C Glass, C Champ, JJ Evans, ... Journal of clinical oncology 28 (18), 3048-3053, 2010	388	2010
Differentiation and definition of vascular-targeted therapies DW Siemann, MC Bibby, GG Dark, AP Dicker, FALM Eskens, ... Clinical Cancer Research 11 (2), 416-420, 2005	354	2005
The meaning of p16^ink4a expression in tumors: Functional significance, clinical associations and future developments AK Witkiewicz, KE Knudsen, AP Dicker, ES Knudsen Cell cycle 10 (15), 2497-2503, 2011	340	2011
Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials N Ohri, X Shen, AP Dicker, LA Doyle, AS Harrison, TN Showalter Journal of the National Cancer Institute 105 (6), 387-393, 2013	318	2013
The role of lineage plasticity in prostate cancer therapy resistance H Beltran, A Hruszkewycz, HI Scher, J Hildesheim, J Isaacs, EY Yu, ... Clinical cancer research 25 (23), 6916-6924, 2019	305	2019
Telemedicine training in undergraduate medical education: mixed-methods review S Waseh, AP Dicker JMIR medical education 5 (1), e12515, 2019	295	2019
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere) DS Grant, TL Williams, M Zahaczewsky, AP Dicker International journal of cancer 104 (1), 121-129, 2003	288	2003
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ... The lancet oncology 15 (13), 1469-1480, 2014	280	2014

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori